← Back to Analyst Consensus 
INGR Hold
Ingredion Inc
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 14, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Oct 5, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 5, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 5, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Jun 9, 2026 | Oppenheimer | downgrade | Outperform → Perform | — | 52% |
| May 6, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Apr 22, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Apr 9, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Mar 17, 2026 | Benchmark | initiate | — → Buy | — | 54% |
| Feb 5, 2026 | UBS | maintain | Neutral → Neutral | $124 | 54% |
| Feb 4, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | $128 | 53% |
| Feb 4, 2026 | Stephens & Co. | reiterate | Equal-Weight → Equal-Weight | $120 | 54% |
| Nov 6, 2025 | Barclays | downgrade | Overweight → Equal-Weight | $124 | 53% |
| Nov 5, 2025 | UBS | maintain | Neutral → Neutral | $119 | 54% |
| Nov 5, 2025 | Stephens & Co. | maintain | Equal-Weight → Equal-Weight | $120 | 54% |
| Nov 5, 2025 | BMO Capital | maintain | Market Perform → Market Perform | $123 | 53% |
| Oct 6, 2025 | UBS | maintain | Neutral → Neutral | $130 | 54% |
| Jul 9, 2025 | UBS | maintain | Neutral → Neutral | $151 | 54% |
| Apr 22, 2025 | Oppenheimer | maintain | Outperform → Outperform | $155 | 52% |
| Apr 7, 2025 | UBS | downgrade | Buy → Neutral | $145 | 54% |
| Feb 5, 2025 | Oppenheimer | maintain | Outperform → Outperform | $167 | 52% |
| Feb 5, 2025 | BMO Capital | maintain | Market Perform → Market Perform | $133 | 53% |
| Feb 5, 2025 | Stephens & Co. | maintain | Equal-Weight → Equal-Weight | $150 | 54% |
| Nov 15, 2024 | UBS | maintain | Buy → Buy | $173 | 54% |
| Nov 6, 2024 | BMO Capital | maintain | Market Perform → Market Perform | $147 | 53% |
| Nov 6, 2024 | Barclays | maintain | Overweight → Overweight | $168 | 53% |
| Nov 6, 2024 | Oppenheimer | maintain | Outperform → Outperform | $178 | 52% |
| Oct 21, 2024 | Oppenheimer | maintain | Outperform → Outperform | $147 | 52% |
| Aug 15, 2024 | UBS | maintain | Buy → Buy | $148 | 54% |
| Aug 9, 2024 | Barclays | upgrade | Equal-Weight → Overweight | $145 | 53% |
| Aug 7, 2024 | BMO Capital | maintain | Market Perform → Market Perform | $128 | 53% |
| Aug 7, 2024 | Oppenheimer | maintain | Outperform → Outperform | $138 | 52% |
| May 9, 2024 | BMO Capital | maintain | Market Perform → Market Perform | $120 | 53% |
| Mar 6, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $122 | 53% |
| Feb 16, 2024 | Goldman Sachs | maintain | Buy → Buy | $135 | 54% |
| Feb 15, 2024 | Goldman Sachs | upgrade | Neutral → Buy | $135 | 54% |
| Feb 7, 2024 | Stephens & Co. | reiterate | Overweight → Overweight | $130 | 54% |
| Nov 13, 2023 | UBS | maintain | Buy → Buy | $136 | 54% |
| Nov 8, 2023 | Stephens & Co. | reiterate | Overweight → Overweight | $130 | 54% |
| Nov 1, 2023 | Barclays | maintain | Equal-Weight → Equal-Weight | $110 | 53% |
| Sep 29, 2023 | Oppenheimer | initiate | — → Outperform | $120 | 52% |
| Aug 9, 2023 | BMO Capital | maintain | Market Perform → Market Perform | $117 | 53% |
| Aug 9, 2023 | Stephens & Co. | reiterate | Overweight → Overweight | $130 | 54% |
| Jun 1, 2023 | Barclays | maintain | Equal-Weight → Equal-Weight | $118 | 53% |
| May 4, 2023 | BMO Capital | maintain | — → Market Perform | $123 | 53% |
| May 4, 2023 | Stephens & Co. | maintain | — → Overweight | $130 | 54% |
| May 4, 2023 | Barclays | maintain | — → Equal-Weight | $120 | 53% |
| Apr 13, 2023 | UBS | upgrade | Neutral → Buy | $121 | 54% |
| Mar 17, 2023 | Stephens & Co. | reiterate | — → Overweight | $120 | 54% |
| Feb 9, 2023 | Credit Suisse | maintain | — → Neutral | $110 | — |
Price Target Trend
Jun 25, 2026 Latest: $119.5 Oct 25, 2026
EPS Estimates
0y $10.46
Lo: $10.16 Hi: $10.63
7 analysts 0q $2.60
Lo: $2.53 Hi: $2.64
6 analysts +1y $11.23
Lo: $10.80 Hi: $11.84
7 analysts +1q $2.67
Lo: $2.39 Hi: $2.80
6 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days